Staging
Surgically, endometriosis can be staged I–IV by the revised classification of the American Society of Reproductive Medicine from 1997. The process is a complex point system that assesses lesions and adhesions in the pelvic organs, but it is important to note staging assesses physical disease only, not the level of pain or infertility. A person with Stage I endometriosis may have a little disease and severe pain, while a person with Stage IV endometriosis may have severe disease and no pain or vice versa. In principle the various stages show these findings:Stage I (Minimal)

Findings restricted to only superficial lesions and possibly a few filmy adhesions.Stage II (Mild)

In addition, some deep lesions are present in the cul-de-sac.Stage III (Moderate)

As above, plus the presence of endometriomas on the ovary and more adhesions.Stage IV (Severe)

As above, plus large endometriomas, extensive adhesions. Implants and adhesions may be found beyond the uterus. Large ovarian cysts are common. Markers
An area of research is the search for endometriosis markers.In 2010, essentially all proposed biomarkers for endometriosis were of unclear medical use, although some appear to be promising. The one biomarker that has been in use over the last 20 years is CA-125. A 2016 review found that this biomarker was present in those with symptoms of endometriosis; and, once ovarian cancer has been ruled out, a positive CA-125 may confirm the diagnosis. Its performance in ruling out endometriosis is low.
Infected ulcers are administered antibiotics. Skin grafting is one option. It has been shown that ultrasound may increase the acceptance of a graft at trophic ulcer sites. See also
List of cutaneous conditions

References


== External links ==